Article info

Download PDFPDF
The UK Risk-Sharing Scheme for interferon-beta and glatiramer acetate in multiple sclerosis. Outcome of the year-6 analysis

Authors

  1. Correspondence to Dr Martin Duddy, Department of Neurology, Newcastle upon Tyne Hospitals Trust, Queen Victoria Road, Newcastle upon Tyne NE1 4LP, UK; martin.duddy{at}nuth.nhs.uk
View Full Text

Citation

Duddy M, Palace J
The UK Risk-Sharing Scheme for interferon-beta and glatiramer acetate in multiple sclerosis. Outcome of the year-6 analysis

Publication history

  • Accepted September 8, 2015
  • First published October 1, 2015.
Online issue publication 
January 14, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.